Acro Biomedical (ACBM) Total Debt Growth (3y) (2019 - 2022)
Analysis
Acro Biomedical (ACBM) Total Debt Growth (3y) (2019 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | -4.39% |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 0.17% |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | -7.13% |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | -6.12% |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | -9.61% |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | -6.18% |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | -8.40% |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | -1.72% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | 82.17% |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 44.22% |
| Sep 30, 2022 | 8.36% |
| Jun 30, 2022 | -40.99% |
| Mar 31, 2022 | 4.54% |
| Dec 31, 2021 | 85.18% |
| Sep 30, 2021 | -48.17% |
| Jun 30, 2021 | -51.59% |
| Mar 31, 2021 | 39.30% |
| Dec 30, 2020 | 80.42% |
| Sep 30, 2020 | 72.88% |
| Jun 30, 2020 | 67.58% |
| Mar 31, 2020 | 92.38% |
| Dec 31, 2019 | 38.00% |
| Sep 30, 2019 | 83.48% |